tradingkey.logo
tradingkey.logo
검색

Pharming Group NV

PHAR
관심 목록에 추가
12.600USD
-0.350-2.70%
종가 11-13 16:00(ET)
891.80M시가총액
0.00P/E TTM

Pharming Group NV 정보 회사

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Pharming Group NV 프로필

종목 코드 PHAR
회사 이름Pharming Group NV
상장일Jul 02, 1998
CEOChouraqui (Fabrice)
직원 수- -
유형Depository Receipt
회계 연도 종료- -
주소Darwinweg 24
도시LEIDEN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Netherlands
우편 번호2333 CR
전화31715247400
웹사이트https://www.pharming.com/
종목 코드 PHAR
상장일Jul 02, 1998
CEOChouraqui (Fabrice)

Pharming Group NV의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Ruud van Outersterp
Mr. Ruud van Outersterp
Chief Legal and Compliance Officer, Company Secretary
Chief Legal and Compliance Officer, Company Secretary
--
--
Ms. Maryana Reurings-Tsiganko
Ms. Maryana Reurings-Tsiganko
Vice President - Strategy and Operations
Vice President - Strategy and Operations
--
--
Dr. Elaine Sullivan, Ph.D.
Dr. Elaine Sullivan, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Leverne Marsh
Ms. Leverne Marsh
Interim Co-Chief Executive Officer, Chief Commercial Officer
Interim Co-Chief Executive Officer, Chief Commercial Officer
--
--
Mr. Kenneth Lynard
Mr. Kenneth Lynard
Interim Co-Chief Executive Officer, Chief Financial Officer
Interim Co-Chief Executive Officer, Chief Financial Officer
--
--
Ms. Ines Bernal
Ms. Ines Bernal
Chief People Officer
Chief People Officer
--
--
Mr. Fabrice Chouraqui, Pharm.D.
Mr. Fabrice Chouraqui, Pharm.D.
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Dr. Alexander Breidenbach, Ph.D.
Dr. Alexander Breidenbach, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
Dr. Richard Peters, M.D., Ph.D.
Dr. Richard Peters, M.D., Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Stephen (Steve) Toor
Mr. Stephen (Steve) Toor
Chief Commercial Officer
Chief Commercial Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Ruud van Outersterp
Mr. Ruud van Outersterp
Chief Legal and Compliance Officer, Company Secretary
Chief Legal and Compliance Officer, Company Secretary
--
--
Ms. Maryana Reurings-Tsiganko
Ms. Maryana Reurings-Tsiganko
Vice President - Strategy and Operations
Vice President - Strategy and Operations
--
--
Dr. Elaine Sullivan, Ph.D.
Dr. Elaine Sullivan, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Leverne Marsh
Ms. Leverne Marsh
Interim Co-Chief Executive Officer, Chief Commercial Officer
Interim Co-Chief Executive Officer, Chief Commercial Officer
--
--
Mr. Kenneth Lynard
Mr. Kenneth Lynard
Interim Co-Chief Executive Officer, Chief Financial Officer
Interim Co-Chief Executive Officer, Chief Financial Officer
--
--
Ms. Ines Bernal
Ms. Ines Bernal
Chief People Officer
Chief People Officer
--
--

자주 묻는 질문

Pharming Group NV의 상위 5대 주주는 누구인가요?

Pharming Group NV의 상위 5대 주주는 다음과 같습니다: Mr. Stephen (Steve) Toor

Pharming Group NV(PHAR)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Pharming Group NV의 주식을 보유한 기관은 총 22곳이며, 이들이 보유한 주식의 총 가치는 약 135.73K로 전체 발행 주식의 0.19%를 차지합니다. 이는 2025Q4 대비 61813.00 증가한 수치입니다.
tradingkey.logo
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유